Identification of new angiogenic regulatory events, markers and targets for anti- or pro-angiogenic therapies (ANGIONET)

Objective

A wide range of common and lethal pathologies such as cardiovascular diseases, tumour growth and metastatic spread, are linked to the disruption of the angiogenic balance. The antiangiogenic treatments currently in clinical trials for cancer generally target a limited number of events involved in the angiogenic process. There is a pressing need to expand the number of therapeutic targets in this area. The consortium partner laboratories contribute expertise on a wide spectrum of cellular and in vivo models, providing a comprehensive representation of specific steps in neovascularization. These models will be processed by genomics analysis and promising genes will be pre-selected in vitro. The selected genes will be assessed and compared in the set of physiological and pathological models. This strategy will lead to the identification of novel critical genes and define their role in angiogenesis.

Fields of science

• natural sciences › biological sciences › genetics
• medical and health sciences › clinical medicine › cardiology › cardiovascular diseases
• medical and health sciences › clinical medicine › oncology
• medical and health sciences › basic medicine › pathology

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Call for proposal

Data not available

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

AVENTIS PHARMA RECHERCHE DEVELOPPEMENT S.A.

Address

Quai Jules Guesde 13
94403 Vitry Sur Seine
France

Participants (4)

FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW

Belgium

Address

49,herestraat 49 Kul / Campus Gasthuisberg
3000 Louvain / Leuven

MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.

Germany

Address

Benekestrasse 2
61231 Bad Nauheim

TUMOR BIOLOGY CENTRE FREIBURG

Germany

Address

Breisacher Strasse 117
79106 Freiburg (In Breisgau)

UNIVERSITY OF HELSINKI

Finland

Address

3,haartmaninkatu 8
00014 Helsinki